Back to Search Start Over

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors :
Felder, Mildred
Kapur, Arvinder
Gonzalez-Bosquet, Jesus
Horibata, Sachi
Heintz, Joseph
Albrecht, Ralph
Fass, Lucas
Kaur, Justanjyot
Hu, Kevin
Shojaei, Hadi
Whelan, Rebecca J.
Patankar, Manish S.
Source :
Molecular Cancer; 2014, Vol. 13 Issue 1, p1-36, 36p, 1 Black and White Photograph, 2 Diagrams, 3 Graphs
Publication Year :
2014

Abstract

Over three decades have passed since the first report on the expression of CA125 by ovarian tumors. Since that time our understanding of ovarian cancer biology has changed significantly to the point that these tumors are now classified based on molecular phenotype and not purely on histological attributes. However, CA125 continues to be, with the recent exception of HE4, the only clinically reliable diagnostic marker for ovarian cancer. Many large-scale clinical trials have been conducted or are underway to determine potential use of serum CA125 levels as a screening modality or to distinguish between benign and malignant pelvic masses. CA125 is a peptide epitope of a 3-5 million Da mucin, MUC16. Here we provide an in-depth review of the literature to highlight the importance of CA125 as a prognostic and diagnostic marker for ovarian cancer. We focus on the increasing body of literature describing the biological role of MUC16 in the progression and metastasis of ovarian tumors. Finally, we consider previous and on-going efforts to develop therapeutic approaches to eradicate ovarian tumors by targeting MUC16. Even though CA125 is a crucial marker for ovarian cancer, the exact structural definition of this antigen continues to be elusive. The importance of MUC16/CA125 in the diagnosis, progression and therapy of ovarian cancer warrants the need for in-depth research on the biochemistry and biology of this mucin. A renewed focus on MUC16 is likely to culminate in novel and more efficient strategies for the detection and treatment of ovarian cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14764598
Volume :
13
Issue :
1
Database :
Complementary Index
Journal :
Molecular Cancer
Publication Type :
Academic Journal
Accession number :
96360558
Full Text :
https://doi.org/10.1186/1476-4598-13-129